Alcohol-associated liver disease
Open accessThe DOI matches its Crossref record; 199 of the 202 references it cites were found in a registry or an index.
Abstract
Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide, and comprises a spectrum of several different disorders, including simple steatosis, steatohepatitis, cirrhosis, and superimposed hepatocellular carcinoma. Although tremendous progress has been made in the field of ALD over the last 20 years, the pathogenesis of ALD remains obscure, and there are currently no FDA-approved drugs for the treatment of ALD. In this Review, we discuss new insights into the pathogenesis and therapeutic targets of ALD, utilizing the study of multiomics and other cutting-edge approaches. The potential translation of these studies into clinical practice and therapy is deliberated. We also discuss preclinical models of ALD, interplay of ALD and metabolic dysfunction, alcohol-associated liver cancer, the heterogeneity of ALD, and some potential translational research prospects for ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In ALD, hepatocyte cell death results in the release of DAMPs that, together with gut-derived PAMPs, activate surrounding immune cells and serve as recruiting signals for circulating immune cells [82, 83].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358 · cited 1×
“Alcohol-associated cirrhosis causes an estimated 25% of global deaths due to liver cirrhosis and up to 40% in certain areas of Europe (146).”
BackgroundMarrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539 · cited 1×
“Cirrhosis is a necessary intermediate step for A-HCC development and amplifies the overall risk for carcinogenesis in patients with ALD (157, 158).”
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100 · cited 1×
“…liver disease, which encompasses all types of fatty liver diseases, now termed MASLD, which replaces the stig-matizing “nonalcoholic fatty liver disease” (NAFLD), and a new category, called MetALD, which includes patients with MASLD who also have significant alcohol consumption (143, 144).”
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Self-citationResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 1×
“Indeed, by utilizing scRNA-Seq analysis, two studies have identified new cell subpopulations that drive fibrosis and inflammation in the mouse AH model and human alcohol-as-sociated cirrhosis (120, 121).”
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480 · cited 1×
“Moreover, alcohol misuse and ALD are associated with small intestinal bacterial overgrowth, alterations of gut microbiota (“dysbiosis”), and bacterial translocation (46, 47).”
BackgroundPathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Self-citationMouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213 · cited 1×
“In 2010, we introduced binge ethanol intake into the chronically ethanol-fed mice, which causes significant neutrophil infiltration and liver injury (23, 133).”
Self-citation
Cited by
Items 101–200 of 361
Navigating the Paradox of IL‐22: Friend or Foe in Hepatic Health?
Qin, J., Zhu, W., & Zhou, W. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16991 · Cited by 9
Lee, D. Y., Ko, J.-H., Jang, H.-N., Moon, S. J., Kwon, H., Park, S. E., Park, C.-Y., Lee, W., Oh, K. W., & Rhee, E. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2281 · Cited by 9
Tan, Z., Shi, J., Zhang, S., & Liu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682992 · Cited by 9
Ou, T.-Y., Huy, L. Đ., Giang, N. N. T., Dung, N. T. T., Mayne, J., Shih, C., Chang, Y.-M., Abdi, A. A., Hsu, S., Lin, H.-J., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf573 · Cited by 7
Gopal, T., Kathiravan, A. D. J., Kabanov, A. V., Casey, C. A., & Saraswathi, V. (2025) · Biology · doi:10.3390/biology14101319 · Cited by 8
“Despite the severity and prevalence of ALD, there are currently no US Food and Drug Administration (FDA)-approved acceptable therapeutics exist to reverse the disease progression [5].”
Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets
Qian, S., Wang, X., Chen, Y., Zai, Q., & He, Y. (2024) · Seminars in Liver Disease · doi:10.1055/a-2338-9261 · Cited by 7
Saikogenin A improves ethanol-induced liver injury by targeting SIRT1 to modulate lipid metabolism
Ming-zhu, J., Feng, Y., Wang, J., Xu, X., Liu, Z., Li, T., Ma, S., Wang, Y., Guo, X., & Du, S. (2024) · Communications Biology · doi:10.1038/s42003-024-07234-x · Cited by 12
Belvončíková, P., Feješ, A., Gromová, B., Janovičová, Ľ., Farkašová, A., Babál, P., & Gardlík, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051893 · Cited by 7
“Extensive and chronic alcohol consumption leads to steatosis and alcohol-associated steato-hepatitis (ASH) and may progress to cirrhosis and hepatocellular carcinoma [2].”
Dourado, T. M. H., & Tirapelli, C. R. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.07.012 · Cited by 6
Ding, Q., Cao, W., Ge, X., Cao, F., Song, Q., Jin, Y., Sun, T., Fang, H., Li, J., & Li, S. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c01450 · Cited by 9
Interferon in Liver Diseases: Recent Advances
Gao, Y., Yin, Y., Xie, P., Zhang, D., Li, H., & Qi, X. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03291-8 · Cited by 8
Liu, Y., Ruan, Y., Zhao, A., Bian, Z., Bai, J., Niu, S., Wang, S., Huang, Z., Cao, X., Shen, C., et al. (2025) · Food & Function · doi:10.1039/d5fo02499d · Cited by 6
Methionine Adenosyltransferase 1A and S-Adenosylmethionine in Alcohol-Associated Liver Disease
Barbier‐Torres, L., Chhimwal, J., Mato, J. M., & Lu, S. C.-L. (2025) · Antioxidants · doi:10.3390/antiox14121486 · Cited by 6
Manshi, Dash, D., & Koiri, R. K. (2026) · Endocrine · doi:10.1007/s12020-026-04561-3 · Cited by 7
Guo, Y., Li, J., Miao, X., Wang, H., Ge, H., Xu, H., Wang, J., & Wang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123166 · Cited by 5
Fu, J., Zhang, Z., Zhao, Y., Li, X., Jiang, C., He, H., Huo, J., Qi, X., Wu, J., Zhu, F.-X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113550 · Cited by 8
He, Z., Deng, S., Wu, Z., Cui, Z., Mei, H., Wang, J., Wang, K., & Zhang, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119117 · Cited by 8
Hu, Y., Zhang, Z., Adiham, A., Li, H., Gu, J. H., & Gong, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020696 · Cited by 8
Chen, J., Xu, C., He, Q., Ali, M., Safdar, M., Li, X., & Li, K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145793 · Cited by 6
Fan, F., Zhu, F., Jiang, C., Zhang, L., Ali, M. H., Wang, Y., Zhang, K., Zhao, Z., Li, Q., Li, S., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117308 · Cited by 6
IL-1 receptor-associated kinase family proteins: An overview of their role in liver disease
Wang, Z.-Y., Gao, S., Gou, X., Qiu, F., & Feng, Q. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176773 · Cited by 5
Xu, X., Zhao, H., Zhang, J., Yan, H., Liu, X., Huo, J., & Huo, L. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102617 · Cited by 5
Wang, Y., Wang, D., Li, Y., He, C., Li, X., Yang, L., & Jin, Y. (2025) · Journal of Ginseng Research · doi:10.1016/j.jgr.2025.10.004 · Cited by 6
“The pathogenesis of ALD is multifactorial and intricately regulated, involving hepatocellular injury and regeneration, oxidative stress, inflammation, dysregulated lipid metabolism, mitochondrial dysfunction, and disturbances of the gut-liver axis [2,6,7].”
Zhang, Y.-J., Cheng, D., Yao, W.-H., Li, H., Zhang, M.-B., Mu, Y.-W., Zhang, X.-N., Song, G., & Zeng, T. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157853 · Cited by 6
Urolithin A regulates gut: liver axis to ameliorate alcohol-associated liver disease
Ghosh, S., Singh, R., Vanwinkle, Z. M., McClain, C. J., Vatsalya, V., Haribabu, B., Vemula, P. K., & Jala, V. R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1706111 · Cited by 5
“Despite its high prevalence and profound economic and health impacts, the clinical management of patients with ALD largely relies on lifestyle changes, including nutritional support and abstinence (Mackowiak et al., 2024).”
Ling, J., Han, Z., Qiu, J., Li, B., Chen, D., Wang, Y., Liu, J., Li, R., Xu, D., Liu, X., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157863 · Cited by 5
Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease
Wang, R., Ma, F., Yin, D., Wang, H., & Wei, X. (2025) · Seminars in Liver Disease · doi:10.1055/a-2601-9480 · Cited by 5
Tetramethylpyrazine: A fermented alcohol product that mitigates alcoholic liver disease in mice
Pu, Q., Gao, H., Xiao, D., Wang, M., Yang, Z., He, Q., Liu, M., Zhu, X., Pan, T., Ma, Z., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.05.415 · Cited by 6
Liao, Y., Guo, J., Gao, Z., Pan, Z., Peng, M., Fu, Y., Fu, F., & Shan, Y. (2025) · Food Frontiers · doi:10.1002/fft2.70021 · Cited by 4
Self-citationLin, Y., Cheng, C., Wei, S., Guillot, A., Mackowiak, B., Pan, H., Fu, Y., Maccioni, L., Ren, T., Zhang, L., et al. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70126 · Cited by 4
Self-citationBiodegradation of Both Ethanol and Acetaldehyde by Acetobacter ghanensis JN01
Liu, H., Wang, J., Xu, Q., Cao, X., Du, X., Lin, K., & Yan, H. (2025) · Catalysts · doi:10.3390/catal15080756 · Cited by 6
Yes‐Associated Protein in Hepatocytes Protects Against Early Alcohol‐Associated Liver Disease
Zhang, X., Yang, X., Sun, X., Qin, Q., Hou, Y., Jia, M., Su, X., & Chen, Y. (2025) · Liver International · doi:10.1111/liv.70372 · Cited by 4
“It notably simulates the pathological characteristics at the initial stage of ALD, that is, hepatic steatosis and mild inflammation [11, 12].”
Deciphering the Role of Oroxylin A in Liver Fibrosis
Wang, S., Wu, J., Sun, J., Chen, W., Tian, Z., Huang, S., & Wang, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530387 · Cited by 4
Chen, Q., Li, C., Ding, W., & Kong, D. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503273 · Cited by 7
Gut microbiota-mediated therapeutic mechanisms of Dendrobium officinale polysaccharide: A review
Wan, R., Wu, J., Cai, R., Pu, X., Wang, Q., Wang, X., Li, H., Yan, S. G., Wang, L., Liu, J., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151361 · Cited by 8
The versatile interplay between steatotic liver disease and liver cancer
Rahbari, M., Gris‐Oliver, A., Ramadori, P., Aicher, D., Sia, D., MALEK, N. P., Loomba, R. S., Bataller, R. A., Llovet, J. M., & Heikenwälder, M. F. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00918-y · Cited by 4
Kim, S.-Y., Oh, K. J., Seo, Y.-R., Kim, Y. W., Song, P. H., & Song, C. (2024) · Antioxidants · doi:10.3390/antiox13091137 · Cited by 8
“Clinical trials in patients with alcohol-associated hepatitis are ongoing for some targeted agents (e.g., IL-22 agonist, DNA hypermethylation inhibitor, anti-ROS) with promising results [13,60].”
Discovery of novel NLRP3 inhibitors based on machine learning and physical methods
Jiang, T., Qian, S., Xu, J., Yu, S., Yang, L., Xu, L., & Yang, X. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01323-y · Cited by 4
“(ASH), cirrhosis, and hepatocellular carcinoma (HCC) [6].”
Wang, J., Chen, B., Cheng, C., Wang, Q., Yang, L., Li, Z., & Lv, X. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111390 · Cited by 4
Diagnosis and Management of Early Stages of ALD
Gratacós‐Ginès, J., Alvarado‐Tápias, E., Aguado, D. M., López‐Pelayo, H., Bataller, R. A., & Pose, E. (2025) · Seminars in Liver Disease · doi:10.1055/a-2541-2892 · Cited by 5
Feng, Z., Geng, Z.-J., Qin, S., Hu, H., Tan, X.-Y., Zeng, S.-Y., Zhou, R.-Y., Ma, X., Liu, Y., & Zhang, Y. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156639 · Cited by 4
CNN-Based Analytical Approach for Liver Disease Classification and Prediction
Syed, A. A., Shaik, A. B., Konatam, S., Kumar, M. V. P., & Gupta, N. (2025) · International Conference on Advancement in Computation & Computer Technologies (InCACCT) · doi:10.1109/incacct65424.2025.11011283 · Cited by 7
“Cirrhosis, due to chronic liver damage, supplants normal liver tissue with scar tissue, which results in the loss of function of the liver and, in extreme cases, the need for liver transplantation [5] – [6].”
Acetylation of proximal cysteine-lysine pairs by alcohol metabolism
McGinnis, C. D., Harris, P. S., Graham, B. I. M., Marentette, J., Michel, C. R., Saba, L. M., Reisdorph, R. M., Roede, J. R., & Fritz, K. S. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103462 · Cited by 3
Farhadi, S., Mohammadi, S., AlKindi, A. Y., & Al-Amri, I. S. (2025) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v16.i1.104535 · Cited by 5
Potential hepatoprotective effect and mechanisms of Ganoderma lucidum polysaccharides
Wang, Y., Sun, Y., Li, B., Xu, J., Wang, S., Xu, H., Jiang, Z., & Wu, X. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.07.024 · Cited by 6
Alcohol-Associated Hepatitis: Translating Pathophysiology into Targeted Clinical Trials
Ma, J., Gao, H., Zeng, G., Huda, N., Jiang, Y., Thoudam, T., Yang, Z., & Liangpunsakul, S. (2025) · Current Hepatology Reports · doi:10.1007/s11901-025-00703-9 · Cited by 4
Regulated necrosis at the crossroads of liver inflammation and cancer development
Vucur, M., Kondylis, V., Brož, P., & Luedde, T. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01147-8 · Cited by 7
Xiaoping, Z., Bo, Y., Yuxin, Y., Meili, N., Boxuan, Y., Niannian, S., Abuduwaili, A., Mansur, S., Rozi, P., Wali, A., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149752 · Cited by 3
Ding, J., Xu, F., Chen, D., Xi, J., Gao, F., Chen, L., Wang, B., Dou, X., Qiu, J., & He, G. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157830 · Cited by 4
Dong, H., Guo, W., & Zhou, Z. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48010092 · Cited by 6
“Alcohol-associated liver disease (ALD) encompasses a clinical and pathological spectrum ranging from steatosis to steatohepatitis, fibrosis, and cirrhosis, representing a major contributor to global liver-related morbidity and mortality [1].”
Mihaila, D. F., Domnariu, H. P., Moga, D. F. C., & Domnariu, C. D. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062257 · Cited by 3
Shu, H., Wu, D., Xie, L., Wang, G., Zhou, H., Zhang, H., Tian, S., Zhang, X., Li, C., Wang, C., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.04.001 · Cited by 5
Li, Y., Huo, Z., Liu, H., Jiang, B., Zhang, Q., Liu, S., & Wu, S. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70967 · Cited by 3
Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives
Li, C. C., Liu, M., Lee, H.-P., Wu, W., & Ma, L. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1787152 · Cited by 3
Necrotic Liver Lesion Resolution: Another Mode of Liver Regeneration
Chen, C., Feng, D., Wang, Y., Yao, T., Mackowiak, B., & Gao, B. (2024) · Seminars in Liver Disease · doi:10.1055/a-2358-9505 · Cited by 3
Self-citationZhang, Y., Zhang, W., Li, Y., Yao, H., Wang, Y., Zhang, X., & Zeng, J. Y. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00211 · Cited by 4
Non-coding RNAs in alcohol-associated liver disease
Zeng, G., Gao, H., Jiang, Y., Huda, N., Thoudam, T., Yang, Z., Ma, J., Sun, J., & Liangpunsakul, S. (2025) · Liver Research · doi:10.1016/j.livres.2025.04.007 · Cited by 4
Wang, D., Sou, S., Rith, S., Touch, S., Tan, M., Virak, V., Du, K., Sik, B., & Nov, P. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04077-6 · Cited by 3
Wang, H., Bian, Y., Li, Y., Yuan, Y., Li, X., Liu, Y., & Wang, X. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178027 · Cited by 4
Xiang, A., Chang, Y., Shi, L., & Zhou, C. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1457969 · Cited by 3
Gripshover, T. C., Treves, R. S., & Hardesty, J. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.05.013 · Cited by 3
Micó-Carnero, M., Rojano-Alfonso, C., Maroto-Serrat, C., Cutrìn, J. C., Casillas-Ramírez, A., & Peralta, C. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1455258 · Cited by 2
Wang, Y., Yuan, M., Li, S., Tang, J., Wan, Y., Liang, X., Guo, Y., & Guo, L. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01197 · Cited by 3
Myeloid-derived MANF ameliorates ethanol-induced liver injury by enhancing microRNA-223 expression
Xie, H., Zhang, P., Yang, S., Du, J., Ren, Y., Gao, X., Li, N., Yang, T., Ma, Y., & Hou, X. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02240-0 · Cited by 3
Resolvin D1 values in patients with alcohol-associated liver disease
Küçük, İ., Salmanoğlu, M., & Baş, S. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04221-2 · Cited by 3
Physiological Mechanisms Vulnerable to Alcohol‐Induced Alterations: Role in Chronic Comorbidities
Simon, L., Couvillion, K. E., Donovan, M. E., Gallegos, E. M., Souza‐Smith, F. M., & Molina, P. E. (2025) · Comprehensive physiology · doi:10.1002/cph4.70057 · Cited by 7
Schnabl, J. T., Sandini, S., Stärkel, P., & Hartmann, P. (2025) · Microorganisms · doi:10.3390/microorganisms13112458 · Cited by 3
“Alcohol-associated steatohepatitis may progress to fibrosis and cirrhosis with continued alcohol consumption [4].”
Zhang, B., Wang, N., Chen, X., Yang, N., Ying, Z., & Zhang, X. (2025) · Molecules · doi:10.3390/molecules30224371 · Cited by 2
“As a highly prevalent chronic liver disease worldwide, alcoholic liver disease (ALD) represents a leading cause of mortality associated with hepatic pathologies [17].”
Lipid‐Based Nanoplatforms in Hepatology: From Rational Design to Clinical Translation Challenges
Wang, J., Zhang, Q., Yang, L., Cheng, Z., Wang, C., Song, R., Dai, H., & Zhang, X. (2025) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70025 · Cited by 4
Yang, F., Li, X., Sun, J., Pang, X., Hu, Y., Chen, C., Lu, Y., & Lv, F. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108352 · Cited by 2
Hu, L., Cheng, H., Pan, J., Liangpunsakul, S., & Wang, Y. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2621522 · Cited by 2
Liu, S., Zhang, H., Du, R., Gao, X., Wang, T., Qin, W., Sun, D., Liang, H., & Wang, P. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c12678 · Cited by 2
Mi, Q.-R., Wu, C.-Q., Lv, C.-G., Zhao, K.-E., Liu, Z.-F., Xu, P., & Li, L. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01726-0 · Cited by 2
Guo, F., Wang, S., Du, Y.-C., Chen, J.-H., Zeng, T., & Zhou, H. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116383 · Cited by 2
Mihaila, D. F., Domnariu, H. P., Moga, D. F. C., & Domnariu, C. D. (2026) · Metabolites · doi:10.3390/metabo16040224 · Cited by 2
“Alcohol consumption can significantly influence drug metabolism through modulation of hepatic cytochrome P450 enzymes, particularly CYP2E1, thereby affecting drug bioavailability, oxidative stress generation, and hepatotoxic risk [8,9,44].”
InfluentialZhu, J., Wang, H., Tang, Z., Yan, X., Dong, J., Ye, C., Wu, Y., Guo, T., Jin, Z., Zhang, Y., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158132 · Cited by 2
Role of ferroptosis in liver diseases and its implications for therapeutic strategies
Zhang, E. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116102 · Cited by 4
Mahalingam, S., Kharbanda, K. K., Casey, C. A., & Rasineni, K. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1752204 · Cited by 3
“The resulting accumulation of fat in hepatocytes makes the liver susceptible to inflammatory mediators and/or toxic agents, leading to progressive injury, which progresses to alcoholic steatohepatitis (ASH), fibrosis, cirrhosis, and cancer (Li et al., 2024; Mackowiak et al., 2024).”
Díaz, L. A., Pose, E., Israelsen, M. E., & Loomba, R. S. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01240-6 · Cited by 5
Role of Neutrophils in the Development of Steatotic Liver Disease
Choi, Y., Kim, Y. S., & Hwang, S. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1789207 · Cited by 3
“71 Bacterial translocation from the gut to the liver plays a critical role in ALD progression, driven by imbalanced gut microbiota and compromised gastrointestinal mucosal integrity, triggering an in fl ammatory cascade, culminating in hepatocyte necrosis, neutrophil in fi ltration, and metabolic…”
Cheng, Y., Rao, P., Li, S., Yu, W., Tang, Y., Wang, R., He, W., & Liu, J. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117117 · Cited by 2
Liu, S., Zhu, K., Huang, Y., Ye, W., & Wu, J. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112407 · Cited by 2
Lemasters, J. J., & Zhong, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15260-3.00026-0 · Cited by 3
Wang, X., Yao, D.-S., Xu, L., Yan, D.-M., Zhao, Y. X., Peng, J., Fu, Q., Hu, Y., & Feng, Q. (2024) · Current Medical Science · doi:10.1007/s11596-024-2955-2 · Cited by 3
Kim, D. Y., Shin, S. C., Kim, G. J., Eom, J.-I., Han, C.-H., Pan, C., & Lee, J. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083851 · Cited by 2
“The concentrated extract was then thermally sterilized at 70 ◦ C for 30 min and subsequently lyophilized to obtain the final product.”
Saito, T., George, J., Ozaki, K., Tsuchishima, M., & Tsutsumi, M. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01210-9 · Cited by 3
Emerging evidence of inter-organ interaction on drug transporters under liver injury
Jiang, L., Deng, Y. J., Mu, R., Feng, W., Liu, X., & Liu, L. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60888-0 · Cited by 3
Key Transcription Factors: Avenue for Treating Alcoholic Liver Disease
Guo, M., Cao, J.-N., Li, X., & Jin, L. (2025) · Current Medical Science · doi:10.1007/s11596-025-00079-3 · Cited by 2
Evidence that extracellular HSPB1 contributes to inflammation in alcohol-associated hepatitis
Overstreet, A.-M. C., Burge, M., Bellar, A., McMullen, M. R., Srivastava, V., Czarnecki, D., Huang, E., Pathak, V., Finney, C., Vij, R., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000768 · Cited by 5
“[4] However, patients can progress to life-threatening disease quickly and without any prior indication.”
InfluentialOxidized HMGB1 Adducts Unleash Inflammation in Alcohol-Associated Liver Disease
Kumar, P., & Tacke, F. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101375 · Cited by 2
Serrazina, J., & Cortez‐Pinto, H. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00948-7 · Cited by 1
Novel intervention for alcohol-associated liver disease
Gao, F.-Q., Zhu, J., & Feng, X. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i39.4308 · Cited by 1
Sharma, N., Bhat, S. H., Chaudhary, S. D., Mathew, B., Pandey, S., Yadav, S., Yadav, M., Bindal, V., Tripathi, G., Sharma, N., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103674 · Cited by 1
Qu, K., Gu, J., Xu, Z., Hepeng, Y., Ning, Q., & Wu, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02660-7 · Cited by 2
“Moreover, alcohol exposure alters the immune microenvironment in the liver [50].”
Liu, Y., Wang, L.-R., Liao, Z.-Q., Xie, X.-B., Deng, Z.-Q., Zhou, B.-Q., Chen, Z.-N., Zhang, C.-B., Liang, Q.-R., & Tang, Q. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115139 · Cited by 1
New insights into lipid droplet breakdown in alcohol-associated hepatic steatosis
Zhang, C., & Ding, W. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202506103 · Cited by 1
Insights on Alcohol-Associated Liver Disease, a Decade of Data from National Survey
Choday, S., Zahdeh, T., Kang, P. T., Reynolds, J. A., & Wong, R. J. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7030052 · Cited by 1
“AALD encompasses a spectrum of liver conditions, ranging from simple steatosis (fatty liver) to alcoholic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) [2].”
InfluentialAbdel‐Salam, O. M. E., Youness, E. R., Morsy, F. A., & Sleem, A. A. (2025) · MOLECULAR SCIENCES AND APPLICATIONS · doi:10.37394/232023.2025.5.7 · Cited by 1
Shen, S., Cao, M., & Sui, Z. (2025) · Medicine · doi:10.1097/md.0000000000044506 · Cited by 1
“[2,11] In this study, we established an in vitro model of alcohol-induced hepatocyte injury and systematically evaluated the protective effects of the natural flavonoid compound SCU on cell viability, apoptosis, inflammation, and oxidative stress.”
Autophagy: A double-edged sword in drug addiction
Sun, C., Yin, X., Zheng, Y., Tian, Y., Li, H. Z., Su, L., & Liu, Q. (2025) · The Innovation Life · doi:10.59717/j.xinn-life.2025.100163 · Cited by 1
Metadata
- Authors
- Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gao, Bin
- Venue
- Journal of Clinical Investigation
- Published
- 2024-02-01
- Volume
- 134
- Issue
- 3
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10836812
- OpenAlex
- W4391540982
- Cited by
- 359
- References
- 202
- Citations by year
- 2026: 129 · 2025: 160 · 2024: 70
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- alcoholic liver disease, alcoholic steatohepatitis, alcoholic cirrhosis, pathogenesis, therapeutic target, multi-omics, preclinical models, metabolic dysfunction, disease heterogeneity, translational research
- MeSH terms
- Ethanol, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Diseases, Alcoholic, Liver Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.